| Bioactivity | Avotaciclib (BEY1107) sulfate is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib sulfate can be used for the research of locally advanced or metastatic pancreatic cancer[1]. |
| CAS | 1983984-04-8 |
| Formula | C13H13N7O5S |
| Molar Mass | 379.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Seufferlein T, et, al. Phase I Trials in Pancreatic Cancer. Translational Pancreatic Cancer Research pp 219-232. |
Avotaciclib sulfate
CAS: 1983984-04-8 F: C13H13N7O5S W: 379.35
Avotaciclib (BEY1107) sulfate is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib s
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.